BioNexus Gene Lab Corp.

Equities

BGLC

US0906282076

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-28 EDT			5-day change	1st Jan Change
0.5199 ^USD	-0.02%		-8.87%	-1.91%

04-16	BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-29	BioNexus Gene Lab Corp. Provides Information to Shareholders	CI

BioNexus Gene Lab Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 15, 2022 at 03:57 pm

BioNexus Gene Lab Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 2.49 million compared to USD 3.09 million a year ago. Net loss was USD 0.138662 million compared to net income of USD 0.028262 million a year ago.
For the six months, sales was USD 5.51 million compared to USD 6.54 million a year ago. Net loss was USD 0.121596 million compared to net income of USD 0.367006 million a year ago.

Latest news about BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
BioNexus Gene Lab Corp. Provides Information to Shareholders	02-29	CI
Certain Common Stock of BioNexus Gene Lab Corp. are subject to a Lock-Up Agreement Ending on 18-JAN-2024.	01-17	CI
Soo Kow Lai Provides Information to Shareholders of BioNexus Gene Lab Corp	01-17	CI
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Bionexus Gene Lab Corp. Announces Resignation of Wei Li Leong as Chief Financial Officer	11-03	CI
BioNexus Gene Lab Names Chi Yuen Leong as CEO	23-10-16	MT
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as the Chief Executive Officer	23-10-16	CI
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as A Director	23-10-16	CI
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Chief Executive Officer	23-10-11	CI
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Board of Directors	23-10-11	CI
BioNexus Gene Lab Corp. Announces Executive Changes	23-09-07	CI
Top Premarket Gainers	23-08-23	MT
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
BioNexus Gene Lab Raises $5.8 Million from Public Share Offering	23-07-24	MT
BioNexus Gene Lab Corp.(NasdaqCM:BGLC) added to NASDAQ Composite Index	23-07-24	CI
Top Midday Gainers	23-07-21	MT
Wall Street Set to Open Higher, Investors Look to End Week on Positive Note	23-07-21	MT
Investors Look to Close Week on Positive Note as US Futures See Mixed Performance Premarket Friday	23-07-21	MT
Top Premarket Gainers	23-07-21	MT
BioNexus Gene Lab Corp. has completed an IPO in the amount of $5 million.	23-07-21	CI
BioNexus Gene Lab Shares Fall in Nasdaq Debut	23-07-20	MT
BioNexus Gene Lab Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
BioNexus Gene Lab Corp. has filed an IPO in the amount of $17.25 million.	23-02-14	CI

Chart BioNexus Gene Lab Corp.

Duration

Period

More charts

Company Profile

BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIONEXUS GENE LAB CORP.	-1.91%	9.19M
MODERNA, INC.	+54.05%	63.85B
IQVIA HOLDINGS INC.	-2.02%	41.83B
LONZA GROUP AG	+40.01%	40.47B
CELLTRION, INC.	-10.22%	27.17B
ICON PUBLIC LIMITED COMPANY	+13.42%	26.52B
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	18.69B
BIO-TECHNE CORPORATION	+2.89%	12.73B
UNITED THERAPEUTICS CORPORATION	+22.40%	12.11B
MEDPACE HOLDINGS, INC.	+27.49%	12.07B

Other Biotechnology & Medical Research